Mankind Pharma Limited — Important, 28-02-2025: General Updates

Mankind Pharma has received an income tax order from the Office of the Dy. Commissioner of Income Tax for the Assessment Year 2021-22, raising an additional tax demand, including interest, of ₹111.68 crore. The company believes the demand lacks legal standing and is confident in its grounds for appeal, expecting no material impact on its financials or operations. This situation highlights a significant tax challenge but also suggests the company is prepared to defend its position, potentially mitigating any adverse effects on shareholder value. Investors should monitor the developments of this appeal closely for any updates that could influence the company's financial outlook.